 Hoth Therapeutics Inc NASDAQ: HOTH has added a new asset, HT-TBI, as a novel, point-of-care therapy to treat secondary brain injury resulting from ischemic stroke and traumatic brain injury TBI. HT-TBI will be developed as a ready-to-use drug-device combination product for use. 